EXTH-13. REDUCTION OF TUMOR BURDEN AND HEARING LOSS WITH A MULTIPLE RECEPTOR TYROSINE KINASE INHIBITOR BRIGATINIB IN A GENETICALLY ENGINEERED MOUSE MODEL OF NEUROFIBROMATOSIS TYPE 2
Smith, Abbi⋅Bessler, Waylan⋅Jiang, Li⋅Li, Xiaohong⋅Lu, Qingbo⋅Yuan, Jin⋅He, Yongzheng⋅Masters, Andi⋅Jones, David⋅Yates, Charles and Clapp, D Wade
Neuro-Oncology, vol. 20, (no. suppl_6), pp. vi87, 20181105. | Journal Article